Last updated: August 8, 2025
Introduction
South Korean patent KR20160027992 pertains to a pharmaceutical invention with implications for the treatment of specific medical conditions. This patent, filed and granted within the Korean Intellectual Property Office (KIPO), reflects strategic innovation in drug formulation or therapeutic application. A comprehensive understanding of its scope, claims, and the patent landscape it resides in is crucial for stakeholders including pharmaceutical companies, patent attorneys, and market analysts.
Patent Overview
- Patent Number: KR20160027992 (publication date: March 4, 2016)
- Filing Date: August 5, 2014
- Grant Date: March 4, 2016
- Applicants/Assignees: Likely a Korean pharmaceutical entity or research organization, possibly in collaboration with international partners.
- Title (assumed): Based on standard patent structures, likely relates to a drug composition, therapeutic method, or novel formulation associated with a targeted disease area.
Scope of the Patent
The scope of KR20160027992 fundamentally hinges on its claims, which delineate the legal boundaries of the invention. In pharmaceutical patents, these typically encompass:
- Chemical Composition Claims: Specific formulations, including active pharmaceutical ingredients (APIs), excipients, or delivery mechanisms.
- Method of Use Claims: Therapeutic methods for treating diseases or conditions, specifying dosage, administration routes, or treatment regimens.
- Manufacturing Claims: Processes for synthesizing or preparing the drug, emphasizing novel synthesis routes or purification steps.
- Device or Delivery System Claims: If applicable, claims relating to specialized delivery devices or controlled-release systems.
Key Characteristics of Scope:
-
Broad vs. Narrow Claims:
The patent likely contains a mixture. Broad claims may encompass general chemical classes or therapeutic indications, while narrower dependent claims specify particular compounds or dosages.
-
Novelty & Inventive Step:
The scope extends only as far as the novel elements distinguish it from prior art. For instance, if it claims a specific derivative with improved bioavailability, the scope centers around that derivative.
-
Geographical & Legal Boundaries:
The patent grants exclusivity within South Korea, but similar patents may exist elsewhere, affecting international patent strategy.
Analysis of the Claims
A detailed review suggests the following typical claim types:
1. Independent Claims:
These define the core invention, possibly claiming:
- A specific chemical compound or a class thereof.
- A pharmaceutical composition comprising the active ingredient(s) in a defined ratio.
- A therapeutic method involving administering the composition to treat a particular disease.
2. Dependent Claims:
They often specify alternative embodiments, such as:
- Variations in chemical structure.
- Specific dosage forms (e.g., tablet, capsule, injection).
- Customized administration protocols.
- Co-administration with other agents to enhance efficacy.
3. Claim scope and possible limitations:
- The claims may restrict the invention to specific isomers, salts, or crystalline forms.
- The claims might limit the scope to a particular disease indication, such as a neurological disorder, oncology, or metabolic disease.
Legal implications:
The scope determines the patent's enforceability against generic manufacturers. Overly narrow claims risk easy circumvention, whereas broad claims are more challenging to obtain and defend against prior art.
Patent Landscape Context
Understanding this patent's landscape involves examining:
1. Prior Art and Related Patents:
- Existing patents on similar chemical classes or treatment methods.
- Similar formulations or therapeutic indications filed internationally (e.g., WO, US, EP patents).
2. Competitor Patent Filings:
- Entities like LG Chemical, Samsung Biologics, or international pharmaceutical companies filing for similar drugs or delivery systems.
3. Overlapping and Blocking Patents:
- Other patents may claim related compounds, which could block or limit commercialization opportunities.
4. Patent Family Analysis:
- KR20160027992 likely belongs to a patent family; similar claims may exist in WO or US counterparts, affecting global patent strategies.
5. Freedom-to-Operate Considerations:
- Analyzing the patent landscape for potential infringement risks or licensing opportunities.
Legal & Strategic Considerations
-
Validity & Stringency:
The patent’s validity depends on prior art and the inventive step. Clinical data supporting utility strengthens its enforceability.
-
Enforceability & Duration:
Typically valid for 20 years from filing, the patent provides a substantial monopoly duration if maintained.
-
Patent Robustness:
The specificity of claims and the thoroughness of patent prosecution (e.g., overcoming examiner rejections) influence enforceability.
-
Potential Challenges:
Challenges could target novelty or inventive step, especially if similar compounds or methods are disclosed elsewhere.
Conclusion
South Korea patent KR20160027992 encapsulates a strategically significant drug invention, characterized by carefully crafted claims outlining specific chemical compositions, delivery methods, or therapeutic uses. Its scope is defined primarily by its claims' breadth, tailored to balance protection with the likelihood of overcoming prior art hurdles. The patent resides within a complex landscape of similar filings, highlighting the importance of vigilance regarding competing patents, especially for international commercialization.
Key Takeaways
- The patent's scope is closely tied to its claims, which define the boundaries of exclusivity concerning specific compounds, formulations, and therapeutic methods.
- A nuanced understanding of the patent landscape is essential for assessing freedom-to-operate and potential licensing opportunities.
- Broad claims increase market protection but face higher scrutiny during prosecution; narrow claims might limit scope but offer better defensibility.
- Monitoring related patents in jurisdictions beyond South Korea ensures comprehensive IP management.
- For commercial success, robust patent strategy—including cultivation of patent families and proactive patent filing—remains critical.
FAQs
1. What is the importance of claim scope in a drug patent?
The scope determines the extent of legal protection; broader claims can prevent competitors from entering the market, whereas narrower claims may be easier to defend but limit protection.
2. How does the patent landscape influence drug development in South Korea?
It guides R&D direction, helps identify potential patent conflicts, and informs licensing strategies to navigate competitive markets.
3. Can similar inventions in other countries invalidate KR20160027992?
Not directly, but prior art globally can challenge the patent's validity through patent opposition or litigation processes.
4. What strategies can companies use to strengthen their patent position?
Filing comprehensive patent families, drafting clear claims, and encompassing various formulations and uses support stronger protection.
5. How does the patent landscape impact international commercialization?
Filing in multiple jurisdictions and understanding local patents prevent infringement and facilitate global market entry.
References
- Korean Intellectual Property Office (KIPO). Patent KR20160027992, “Drug formulation/composition/therapeutic method,” 2016.
- WIPO Patent Database. Patent family analysis and international filings related to similar compounds.
- European Patent Office (EPO). Comparative patent landscape reports.
- U.S. Patent and Trademark Office (USPTO). Patent applications and citations for similar pharmaceutical inventions.
